Dual-Responsive Methotrexate-Human Serum Albumin Complex-Encapsulated Liposomes for Targeted and Enhanced Atherosclerosis Therapy
Our formulations work with safety in mind, and it also highlights the potential of precisely targeted and on-demand-released dual-responsive smart nanoplatforms as promising therapeutic options to penetrate deeper plaques for the effective treatment of AS.
Authors
- Xiangyu Zhou (ORCID: https://orcid.org/0000-0001-8976-9489)
- Xiaodong Chen (ORCID: https://orcid.org/0000-0002-5839-7886)
- Yu Nie (ORCID: https://orcid.org/0000-0001-8647-1206)
- Amy Han (ORCID: https://orcid.org/0000-0001-5012-8262)
- Xueqin Wang (ORCID: https://orcid.org/0000-0001-9134-5327)
- Chunhong Li (ORCID: https://orcid.org/0000-0002-6271-3992)
- Chengxi Wu
- Jun Jiang (ORCID: https://orcid.org/0000-0003-1292-7236)
- Huiping Ji (ORCID: https://orcid.org/0000-0002-0568-8604)
Institutions
- Sichuan University (CN)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Beijing University of Chemical Technology (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ijn.s502850
- Citations
- 2
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.19